Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1993 Jun;61(6):2289–2295. doi: 10.1128/iai.61.6.2289-2295.1993

Protective anti-idiotype antibodies in the primate model of pyelonephritis.

M B Kaack 1, L N Martin 1, S B Svenson 1, G Baskin 1, R H Steele 1, J A Roberts 1
PMCID: PMC280847  PMID: 8099064

Abstract

The adherence of P-fimbriated Escherichia coli to a receptor containing alpha-D-Gal-(1-4)-beta-D-Gal (Gal-Gal) on urothelial cells is an important pathogenic mechanism in the development of pyelonephritis. Antibodies (Ab1) that had been produced by immunization with Gal-Gal conjugated with bovine serum albumin were specifically purified and used to stimulate the production of anti-idiotypic antibodies (Ab2) in cynomolgus monkeys (Macaca fascicularis). While sera from all of the Ab2-producing monkeys contained antibodies reactive with Ab1 and P-fimbriae, not all of the sera inhibited P-fimbrial binding to the Gal-Gal receptor. On the basis of the inhibition of binding, Ab2-producing monkeys were divided into two groups, termed reactive and nonreactive. The reactive and nonreactive Ab2-producing monkeys, together with a group of control monkeys, were challenged with a renal inoculation with P-fimbriated Escherichia coli. Hematologic, immunologic, microbiologic, and pathologic data were compared among the three groups. The reactive monkeys, whose Ab2 in serum inhibited binding between P-fimbriae and the Gal-Gal receptor, were protected against renal damage compared with the control group. The nonreactive group shared some parameters with the reactive group but overall developed renal damage comparable to that of the controls.

Full text

PDF
2289

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Daugharty H., Hopper J. E., MacDonald A. B., Nisonoff A. Quantitative investigations of idiotypic antibodies. I. Analysis of precipitating antibody populations. J Exp Med. 1969 Nov 1;130(5):1047–1062. doi: 10.1084/jem.130.5.1047. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Janson K. L., Roberts J. A. Experimental pyelonephritis. V. Functional characteristics of pyelonephritis. Invest Urol. 1978 Mar;15(5):397–400. [PubMed] [Google Scholar]
  3. Jerne N. K. Towards a network theory of the immune system. Ann Immunol (Paris) 1974 Jan;125C(1-2):373–389. [PubMed] [Google Scholar]
  4. Kaack M. B., Pere A., Korhonen T. K., Svenson S. B., Roberts J. A. P-fimbriae vaccines. I. Cross reactive antibodies to heterologous P-fimbriae. Pediatr Nephrol. 1989 Oct;3(4):386–390. doi: 10.1007/BF00850212. [DOI] [PubMed] [Google Scholar]
  5. Kennedy R. C., Melnick J. L., Dreesman G. R. Antibody to hepatitis B virus induced by injecting antibodies to the idiotype. Science. 1984 Mar 2;223(4639):930–931. doi: 10.1126/science.6198721. [DOI] [PubMed] [Google Scholar]
  6. Korhonen T. K., Nurmiaho E. L., Ranta H., Edén C. S. New Method for isolation of immunologically pure pili from Escherichia coli. Infect Immun. 1980 Feb;27(2):569–575. doi: 10.1128/iai.27.2.569-575.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Nisonoff A., Lamoyi E. Implications of the presence of an internal image of the antigen in anti-idiotypic antibodies: possible application to vaccine production. Clin Immunol Immunopathol. 1981 Dec;21(3):397–406. doi: 10.1016/0090-1229(81)90228-2. [DOI] [PubMed] [Google Scholar]
  8. Paque R. E., Miller R., Thomas V. Polyclonal anti-idiotypic antibodies exhibit antigenic mimicry of limited type 1 fimbrial proteins of Escherichia coli. Infect Immun. 1990 Mar;58(3):680–686. doi: 10.1128/iai.58.3.680-686.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Roberts J. A., Hardaway K., Kaack B., Fussell E. N., Baskin G. Prevention of pyelonephritis by immunization with P-fimbriae. J Urol. 1984 Mar;131(3):602–607. doi: 10.1016/s0022-5347(17)50513-3. [DOI] [PubMed] [Google Scholar]
  10. Roberts J. A., Kaack M. B., Baskin G., Korhonen T. K., Svenson S. B., Winberg J. P-fimbriae vaccines. II. Cross reactive protection against pyelonephritis. Pediatr Nephrol. 1989 Oct;3(4):391–396. doi: 10.1007/BF00850213. [DOI] [PubMed] [Google Scholar]
  11. Roberts J. A., Kaack M. B., Baskin G. Treatment of experimental pyelonephritis in the monkey. J Urol. 1990 Jan;143(1):150–154. doi: 10.1016/s0022-5347(17)39900-7. [DOI] [PubMed] [Google Scholar]
  12. Roberts J. A., Roth J. K., Jr, Domingue G., Lewis R. W., Kaack B., Baskin G. Immunology of pyelonephritis in the primate model. V. Effect of superoxide dismutase. J Urol. 1982 Dec;128(6):1394–1400. doi: 10.1016/s0022-5347(17)53516-8. [DOI] [PubMed] [Google Scholar]
  13. Roberts J. A., Roth J. K., Jr, Domingue G., Lewis R. W., Kaack B., Baskin G. Immunology of pyelonephritis in the primate model. VI. Effect of complement depletion. J Urol. 1983 Jan;129(1):193–196. doi: 10.1016/s0022-5347(17)51981-3. [DOI] [PubMed] [Google Scholar]
  14. Sacks D. L., Esser K. M., Sher A. Immunization of mice against African trypanosomiasis using anti-idiotypic antibodies. J Exp Med. 1982 Apr 1;155(4):1108–1119. doi: 10.1084/jem.155.4.1108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Svenson S. B., Hultberg H., Källenius G., Korhonen T. K., Möllby R., Winberg J. P-fimbriae of pyelonephritogenic Escherichia coli: identification and chemical characterization of receptors. Infection. 1983 Jan-Feb;11(1):61–67. doi: 10.1007/BF01651362. [DOI] [PubMed] [Google Scholar]
  16. Svenson S. B., Källenius G., Möllby R., Hultberg H., Winberg J. Rapid identification of P-fimbriated Escherichia coli by a receptor-specific particle agglutination test. Infection. 1982;10(4):209–214. doi: 10.1007/BF01666912. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES